We are live on ! Find out more
GIP

Greatmark Investment Partners Portfolio holdings

AUM $906M
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+16.08%
3 Year Est. Return
+61.99%
5 Year Est. Return
+81.88%
10 Year Est. Return
+373.67%
AUM
$405M
AUM Growth
+$39.7M
Cap. Flow
+$5.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
40.88%
Holding
138
New
5
Increased
56
Reduced
36
Closed
5

Top Buys

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$1.56M
2
KSS icon
Kohl's
KSS
+$967K
3
WFC icon
Wells Fargo
WFC
+$837K
4
RHI icon
Robert Half
RHI
+$577K
5
ELV icon
Elevance Health
ELV
+$410K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$683K
2
GPN icon
Global Payments
GPN
+$645K
3
EMR icon
Emerson Electric
EMR
+$537K
4
MSFT icon
Microsoft
MSFT
+$526K
5
AAPL icon
Apple
AAPL
+$428K

Sector Composition

Rank Sector Weight
1 Technology 23.4%
2 Financials 18.19%
3 Healthcare 14.6%
4 Industrials 12.73%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPR icon
101
Tapestry
TPR
$32.8B
$345K 0.09%
12,779
-775
-6% -$20.2K
PAYX icon
102
Paychex
PAYX
$42.7B
$341K 0.08%
4,014
SCHW
103
Charles Schwab
SCHW
$187B
$333K 0.08%
7,000
NEM icon
104
Newmont
NEM
$119B
$332K 0.08%
7,638
-75
-1% -$2.93K
NSC icon
105
Norfolk Southern
NSC
$75.1B
$332K 0.08%
1,710
-15
-0.9% -$2.81K
VAL
106
DELISTED
Valaris plc Class A Ordinary Share
VAL
$325K 0.08%
49,550
+2,975
+6% +$14.5K
VZ icon
107
Verizon
VZ
$196B
$321K 0.08%
5,232
-100
-2% -$6.03K
TMO icon
108
Thermo Fisher Scientific
TMO
$220B
$317K 0.08%
975
+4
+0.4% +$1.21K
TIP icon
109
iShares TIPS Bond ETF
TIP
$14.5B
$316K 0.08%
2,710
GOOG icon
110
Alphabet (Google) Class C
GOOG
$4.32T
$299K 0.07%
4,480
+80
+2% +$5.16K
NKE icon
111
Nike
NKE
$61.9B
$299K 0.07%
2,950
MMM icon
112
3M
MMM
$94.3B
$298K 0.07%
2,021
ACN icon
113
Accenture
ACN
$108B
$286K 0.07%
1,360
MO icon
114
Altria Group
MO
$114B
$281K 0.07%
5,639
META icon
115
Meta Platforms (Facebook)
META
$1.51T
$275K 0.07%
1,338
-217
-14% -$42K
AN icon
116
AutoNation
AN
$6.92B
$273K 0.07%
5,615
BABA icon
117
Alibaba
BABA
$308B
$266K 0.07%
1,253
BF.B icon
118
Brown-Forman Class B
BF.B
$13.1B
$262K 0.06%
+3,875
New +$252K
USB icon
119
US Bancorp
USB
$99.6B
$259K 0.06%
4,375
AOM icon
120
iShares Core Moderate Allocation ETF
AOM
$1.78B
$241K 0.06%
+6,000
New +$238K
FLTB icon
121
Fidelity Limited Term Bond ETF
FLTB
$415M
$239K 0.06%
4,700
VLO icon
122
Valero Energy
VLO
$85.9B
$234K 0.06%
2,500
DOV icon
123
Dover
DOV
$28.4B
$231K 0.06%
+2,000
New +$214K
VCSH icon
124
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$227K 0.06%
2,800
PFE icon
125
Pfizer
PFE
$153B
$221K 0.05%
5,942
-1,054
-15% -$37.5K

Similar funds

Greatmark Investment Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Greatmark Investment Partners held 138 positions worth $405M, up 11% from $365M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Greatmark Investment Partners's Q4 2019 filing shows 5 new, 56 increased, 36 reduced and 5 closed positions. Its largest new stake was Occidental Petroleum: 38,984 shares worth $1.61M. The largest sale was Gilead Sciences, an estimated $683K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Greatmark Investment Partners's largest Q4 2019 buy was Occidental Petroleum: 38,984 shares worth $1.61M.
  • Greatmark Investment Partners added most to Kohl's in Q4 2019, an estimated $967K increase.
  • Greatmark Investment Partners's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $683K.
  • Greatmark Investment Partners fully exited Celgene Corp in Q4 2019, selling an estimated $298K.
  • Greatmark Investment Partners's ten largest holdings make up 41% of its $405M portfolio in Q4 2019.
  • Greatmark Investment Partners opened 5 new positions and closed 5 in Q4 2019.
  • Greatmark Investment Partners's portfolio value rose 11% quarter-over-quarter to $405M.

Based on Greatmark Investment Partners's 13F filing for Q4 2019, filed 31 Jan 2020.